Scottish Government Urged to Assess Impact of Proposed Disposable Ban

Regulations by 2FIRSTS.ai

Feb.27.2024

Scottish Government Urged to Assess Impact of Proposed Disposable Ban

Scotland government introduces draft to ban disposable e-cigarettes, ACS urges assessment of impact on illegal market.

According to Talkingretail, the Scottish government has announced a draft proposal to ban the sale of disposable e-cigarettes, and has launched a two-week consultation period. The ban is planned to be implemented in April 2025.

In a letter, the Association of Convenience Stores (ACS) urges the Scottish government to accurately assess the impact of the disposable e-cigarette ban on the black market, and how standard trading teams should allocate resources to tackle this issue.

The latest consumer sentiment survey shows that nearly one quarter (24%) of current disposable e-cigarette users will continue to use disposable products even after the ban is implemented, as they can only obtain these products from the illegal market. An independent retail agency stated that the illegal e-cigarette market currently holds about one third of the e-cigarette transactions in the UK, and that resources for trading standards are insufficient to meet the demands for enforcement access.

ACS Chief Executive Officer James Lowman stated:

The ban on disposable e-cigarettes will primarily impact illegal sellers by pushing more people to seek out their products when they are unable to obtain them from legitimate retailers. A clear plan is needed for the illicit market, and proper consultation with the retail industry is essential to evaluate the effects of the proposed ban.

References:

[1] ACS sets out disposable vape ban concerns in letter to Scottish minister

Also Read:

[1] Scotland to Ban Disposable E-cigarettes by April 1, 2025

[2] Welsh Government Follows Suit in Banning Disposable E-Cigarettes

[3] Scotland: Addressing Smoking and Adolescent E-cigarette Use in UK

[4] Scottish Lutheran Committee Warns Ban on Disposable E-cigarettes

#Europe #Legislation #Disposable e-cigarettes #Scotland

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

Following Japan debut, IQOS ILUMA i “Seletti Edition” limited series launches in South Korea.

Philip Morris International (PMI) Korea announced a collaboration with Italian design brand Seletti to launch the IQOS ILUMA i limited “Seletti Edition.” Pre-sales begin on the 29th at IQOS.com for IQOS Club Gold and Platinum members, with sales from the 30th via the website and nine IQOS-owned stores nationwide. PMI previously said the series would debut in Japan first before rolling out to 13 global travel-retail markets.

Oct.29 by 2FIRSTS.ai

From Partnership to Acquisition: Why KT&G Is Betting on the Global Nicotine Pouch Market

As global competition in the nicotine pouch market accelerates, Korea’s tobacco major KT&G has moved with a “Partnership + Acquisition” strategy, teaming up with Altria to acquire Nordic pouch maker Another Snus Factory (brand “LOOP”). Why deploy capital now, and why take this route? Drawing on company disclosures, regulatory monitoring and on-site observations from InterTabac Dortmund, 2Firsts analyzes KT&G’s strategic calculus and the signals behind this move.

Nov.05

PMI Japan Unveils Limited-Edition IQOS ILUMA i “Galaxy Blue,” Priced Around $47

Philip Morris Japan announced it will release the limited-edition IQOS ILUMA i “Galaxy Blue” across IQOS stores nationwide starting October 29, priced at JPY 6,980 including tax (about USD 47). The new model features a space-themed design, with a members-only promotion to run at the Nagoya IQOS store.